Ilter Pınar Birol, Yassa Murat, Dogan Ozan, Tekin Arzu Bilge, Günkaya Osman Samet, Yassa Mahmut, Sacinti Koray Gorkem, Alsannan Baydaa, Dagdeviren Hediye, Tug Niyazi, Kaya Cihan
Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Şehit Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital, İstanbul, Turkey (Drs. Ilter, Murat Yassa, Tekin, Gunkaya, and Tug); Department of Obstetrics and Gynecology, University of Health Sciences Turkey Kartal Dr. Lutfi Kirdar Research and Training Hospital, Istanbul, Turkey (Dr. Ilter).
Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Şehit Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital, İstanbul, Turkey (Drs. Ilter, Murat Yassa, Tekin, Gunkaya, and Tug); Clinic of Obstetrics and Gynecology, Bahçeşehir University, VM Medical Park Maltepe Hospital, İstanbul, Turkey (Dr. Murat Yassa).
J Minim Invasive Gynecol. 2025 Jan;32(1):39-48. doi: 10.1016/j.jmig.2024.09.007. Epub 2024 Sep 12.
We aimed to evaluate the medium-term outcomes of high uterosacral ligament suspension (HUSLS) with vaginal-assisted natural orifice transluminal endoscopic surgery (vNOTES) in patients either having pelvic organ prolapse or undergoing routine prophylaxis to prevent posthysterectomy vaginal vault prolapse.
Multicenter prospective cohort study.
Three tertiary care hospitals.
Patients who received vNOTES-HUSLS between January 1, 2021, and January 1, 2023, were included in the study.
vNOTES-HUSLS.
The data collected included surgery duration, intraoperative and postoperative complications, postoperative visual analog scores, and Female Sexual Function Index pain subdomain scores. The changes in prolapse levels were measured using modified Pelvic Organ Prolapse Quantifications System scores, including the C, Ba, and Bp scores recorded before surgery and during the postoperative follow-up examination. Patient satisfaction was assessed using the Patient Global Impression of Improvement questionnaire. The final analysis included 55 women. Of these, vNOTES-HUSLS was performed in 43 patients (78.2%) to treat apical prolapse, whereas the remaining 12 patients (21.8%) underwent prophylaxis after hysterectomy to prevent vaginal vault prolapse. The median follow-up period was 23.5 months, with a range of 12 to 37 months. Ba, C, and Bp points significantly improved in patients who underwent surgery for prolapse (p <.001). There was no recurrence in the apical compartment after vNOTES-HUSLS for both performed prophylactic and treatment purposes after hysterectomy. Two patients (3.6%) were diagnosed as having stage 3 anterior compartment prolapse. The overall vNOTES-HUSLS success rate was 96.4% at approximately 2-year follow-up. Bladder injury was detected as an intraoperative complication in 1 patient (1.8%). The overall satisfaction rate was 98.1% at the final follow-up.
vNOTES-HUSLS was effective in the treatment and prophylaxis of apical prolapse, demonstrating high anatomic success rates. The procedure demonstrated a low complication rate, with intraoperative and postoperative complications each observed in 1.8% of patients (n = 1).
我们旨在评估采用经阴道自然腔道内镜手术(vNOTES)进行高位骶韧带悬吊术(HUSLS)对盆腔器官脱垂患者或接受常规预防措施以防止子宫切除术后阴道穹窿脱垂患者的中期疗效。
多中心前瞻性队列研究。
三家三级医疗中心。
纳入2021年1月1日至2023年1月1日期间接受vNOTES-HUSLS手术的患者。
vNOTES-HUSLS。
收集的数据包括手术时长、术中及术后并发症、术后视觉模拟评分以及女性性功能指数疼痛子域评分。使用改良的盆腔器官脱垂定量系统评分来测量脱垂程度的变化,包括术前及术后随访检查时记录的C、Ba和Bp评分。使用患者总体改善印象问卷评估患者满意度。最终分析纳入55名女性。其中,43例患者(78.2%)接受vNOTES-HUSLS治疗顶端脱垂,其余12例患者(21.8%)在子宫切除术后接受预防措施以防止阴道穹窿脱垂。中位随访期为23.5个月,范围为12至37个月。接受脱垂手术的患者Ba、C和Bp评分显著改善(p <.001)。子宫切除术后进行预防性和治疗性vNOTES-HUSLS后顶端腔室均无复发。2例患者(3.6%)被诊断为3期前盆腔脱垂。在约2年的随访中,vNOTES-HUSLS的总体成功率为96.4%。1例患者(1.8%)术中检测到膀胱损伤。最终随访时总体满意率为98.1%。
vNOTES-HUSLS在顶端脱垂的治疗和预防方面有效,显示出较高的解剖学成功率。该手术并发症发生率低,术中及术后并发症各在1.8%的患者中观察到(n = 1)。